Reduction of NETosis by targeting CXCR1/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis.

MLA

Alsabani, Mohmad, et al. “Reduction of NETosis by Targeting CXCR1/2 Reduces Thrombosis, Lung Injury, and Mortality in Experimental Human and Murine Sepsis.” British Journal of Anaesthesia, vol. 128, no. 2, Feb. 2022, pp. 283–93. EBSCOhost, https://doi.org/10.1016/j.bja.2021.10.039.

APA

Alsabani, M., Abrams, S. T., Cheng, Z., Morton, B., Lane, S., Alosaimi, S., Yu, W., Wang, G., & Toh, C.-H. (2022). Reduction of NETosis by targeting CXCR1/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis. British Journal of Anaesthesia, 128(2), 283–293. https://doi.org/10.1016/j.bja.2021.10.039

Chicago

Alsabani, Mohmad, Simon T Abrams, Zhenxing Cheng, Ben Morton, Steven Lane, Samar Alosaimi, Weiping Yu, Guozheng Wang, and Cheng-Hock Toh. 2022. “Reduction of NETosis by Targeting CXCR1/2 Reduces Thrombosis, Lung Injury, and Mortality in Experimental Human and Murine Sepsis.” British Journal of Anaesthesia 128 (2): 283–93. doi:10.1016/j.bja.2021.10.039.